Using the same model of A375 tumors, we recently demonstrated that anti-CSPG4 IgE restricted tumor growth in vivo compared to a nonspecific isotype control IgE.34 IgE immunotherapy was associated with enhanced tumor infiltration and activation of monocytes and macrophages with pro-inflammatory phenotype characteristics. Here, CSPG4 is linked to neoplasm.